GSK Investigational Site

Szekszárd 7100

0 studies enrolling now · 5 studies all time

What they study most

Asthma, Crohn's Disease

Studies at this site

• 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old — Completed
• An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease — Stopped early
• A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease — Completed
• Open-Label Extension Study of GSK1605786A — Stopped early
• GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease — Stopped early